Sign in

NCT04106427Completed

Brain Stimulation And Group Therapy to Improve Gesture and Social Skills in Psychosis (BrAGG-SoS)

Brain Stimulation And Group Therapy to Improve Gesture and Social Skills in Psychosis (BrAGG-SoS) - a Randomized, Placebo-controlled, Double-blind Trial of Transcranial Magnetic Stimulation and Group Therapy

Source: ClinicalTrials.gov · Last updated 8 Aug 2025

Brief summary (registry, in English)

Randomized, double-blind, placebo-controlled clinical trial testing the effects of 10 sessions of continuous theta burst stimulation and the effects of 16 sessions of social cognitive remediation therapy on gesture performance and nonverbal communication skills in schizophrenia

Status (registry)
Completed
Study type
Interventional
Enrollment
73 (actual)
First submitted
17 Sept 2019
Start date
1 Dec 2019
Primary completion date
24 Apr 2024
Lead sponsor
University of Bern
NCT number
NCT04106427

What you commit to

  • Study type: Interventional
  • Participants enrolled: 73
  • From 1 Dec 2019 to the primary completion date, 24 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Standard exclusion criteria for cerebral magnetic resonance imaging scanning and transcranial magnetic stimulation (TMS); e.g. metal implants, claustrophobia
  • Patients only: any cognitive remediation therapy in the past 2 years
  • Previous enrolment into the current study,

Other illness

  • Past or current medical or neurological condition associated with impaired or aberrant movement, such as brain tumors, stroke, M. Parkinson, M. Huntington, dystonia, or severe head trauma with subsequent loss of consciousness.
  • Epilepsy or other convulsions
  • History of any hearing problems or ringing in the ears

Other

  • Substance abuse or dependence other than nicotine
  • Patients only: any transcranial magnetic stimulation (TMS) treatment in the past 3 months
  • Women who are pregnant or breast feeding,
  • Intention to become pregnant during the course of the study,
  • Female participants who are surgically sterilised / hysterectomised or post-menopausal for longer than 2 years are not considered as being of child bearing potential.
  • Enrolment of the investigator, his/her family members, employees and other dependent persons

Who the study is looking for

  • Right-handed subjects
  • Ability and willingness to participate in the study
  • Ability to provide written informed consent
  • Informed Consent as documented by signature
  • schizophrenia spectrum disorders according to Diagnostic and statistical manual version 5 (DSM-5)

Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
University of Bern, Translational Research Center, University Hospital of Psychiatry
Coordinator of this site? Confirm its status
BernSwitzerlandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.